Skip to content
StockMarketAgent
Healthcare / Healthcare PlansUpdated 2026-05-10 22:07 UTC

PGNY stock hub

Progyny, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

PGNYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.8B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
PGNY
In the news

Latest news · PGNY

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.7
P25 12.3P50 18.4P75 33.1
Trailing P/E31
P25 14.9P50 23.2P75 38.5
ROE14.9
P25 -105.6P50 -46.5P75 -3.1
ROIC28.3
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All PGNY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
261
Groups with data
11
Currency
USD
Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001551306
Company name
Progyny, Inc.
Country
United States
Country code
US
Cusip
74340E103
Employees
856
Employees Change
176%
Employees Change Percent
25.88
Enterprise value
$1.6B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Healthcare Plans
IPO Date
2019-10-25
Isin
US74340E1038
Last refreshed
2026-05-10
Market cap
$1.8B
Market cap category
Small-Cap
Price
$23.72
Price currency
USD
Rev Per Employee
1,510,662.38x
Sector
Healthcare
Sic
8090
Symbol
PGNY
Website
https://www.progyny.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

16
MetricValue
Earnings Yield
3.68%
EV Earnings
24.23x
EV Sales Forward
1.17x
EV/EBIT
15.74x
EV/EBITDA
14.98x
EV/FCF
8.89x
EV/Sales
1.27x
FCF yield
10.01%
Forward P/E
11.71x
P/B ratio
4.19x
P/E ratio
31.04x
P/S ratio
1.42x
PE Ratio3 Y
42.85x
PE Ratio5 Y
54.77x
PEG ratio
1.11x
PS Forward
1.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
8.06%
EBITDA Margin
8.47%
FCF margin
14.26%
Gross margin
24.11%
Gross Profit
$311.8M
Gross Profit Growth
16.87%
Gross Profit Growth Q
9.6%
Gross Profit Growth3 Y
17.33%
Gross Profit Growth5 Y
30.5%
Net Income
$67.7M
Net Income Growth
28.95%
Net Income Growth Q
60.91%
Net Income Growth Quarters
4%
Net Income Growth Years
1%
Net Income Growth3 Y
16.27%
Net Income Growth5 Y
3.14%
Pretax Margin
8.18%
Profit Margin
5.23%
Profit Per Employee
$79,081
Profitable Years
6
ROA
9.12
Roa5y
6.12
ROCE
22.52
ROE
14.93
Roe5y
15.6
ROIC
28.3
Roic5y
23.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr1y
1.28%
Cagr3y
-11.81%
Cagr5y
-14.43%
EPS Growth
34.91
EPS Growth Q
70.59
EPS Growth Quarters
4
EPS Growth Years
1
EPS Growth3 Y
21.12
EPS Growth5 Y
5.65
FCF Growth
-5.8%
FCF Growth Q
-15.68%
FCF Growth3 Y
19.19%
FCF Growth5 Y
50.5%
OCF Growth
1.55%
OCF Growth Q
-7.75%
OCF Growth3 Y
22.36%
OCF Growth5 Y
53.02%
Revenue Growth
6.59x
Revenue Growth Q
1.38x
Revenue Growth Quarters
27x
Revenue Growth Years
8x
Revenue Growth3 Y
13.99x
Revenue Growth5 Y
27.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$1.81
Assets
$698.3M
Cash
$225.1M
Current Assets
$501.6M
Current Liabilities
$235.7M
Debt
$23.3M
Debt EBITDA
$0.2
Debt Equity
$0.05
Debt FCF
$0.13
Equity
$439.3M
Liabilities
$259M
Long Term Assets
$196.8M
Long Term Liabilities
$23.3M
Net Cash
$201.9M
Net Cash By Market Cap
$10.96
Net Cash Growth
-11.16%
Net Debt EBITDA
$-1.84
Net Debt Equity
$-0.46
Net Debt FCF
$-1.09
Tangible Book Value
$413.5M
Tangible Book Value Per Share
$5.32
WACC
9.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.13
Net Working Capital
$40.7M
Quick ratio
2.07
Working Capital
$265.8M
Working Capital Turnover
$4.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
4.1%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
1.28%
200-day SMA
21.78
3Y total return
-31.41%
50-day SMA
17.9
50-day SMA vs 200-day SMA
50under200
5Y total return
-54.13%
All Time High
68.32
All Time High Change
-65.28%
All Time High Date
2021-11-05
All Time Low
13.29
All Time Low Change
78.48%
All Time Low Date
2019-10-25
ATR
0.9
Beta
0.91
Beta1y
0.58
Beta2y
0.57
Ch YTD
-7.63
High
23.76
High52
28.75
High52 Date
2026-01-13
High52ch
-17.5%
Low
21.19
Low52
16.1
Low52 Date
2026-04-10
Low52ch
47.33%
Ma50ch
32.55%
Premarket Change Percent
24.43
Premarket Price
$23.84
Premarket Volume
17,520
Price vs 200-day SMA
8.9%
RSI
83.87
RSI Monthly
49.75
RSI Weekly
58.3
Sharpe ratio
0.23x
Sortino ratio
0.48
Total Return
4.1%
Tr YTD
-7.63
Tr1m
38.23%
Tr1w
27.53%
Tr3m
8.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
10
Analyst Count Top
1
Analyst Price Target Top
$28
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$0.39
Earnings EPS Estimate Growth
-18.75
Earnings Revenue Estimate
326,722,080x
Earnings Revenue Estimate Growth
0.83x
Operating Income
$104.2M
Operating Income Growth
42.52
Operating Income Growth Q
46.38
Operating Income Growth3 Y
39.46
Operating Income Growth5 Y
31.96
Operating margin
8.06
Price target
$26.5
Price Target Change
$11.72
Price Target Change Top
$18.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
71,016,135%
Float Percent
91.45%
Shares Insiders
1.95%
Shares Institutions
105.35%
Shares Out
77,654,406
Shares Qo Q
-5.26%
Shares Yo Y
-4.1%
Short Float
7.79%
Short Ratio
4.17
Short Shares
7.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

73
MetricValue
Adjusted FCF
$65.3M
Average Volume
1,567,679.65x
Bv Per Share
5.66
CAPEX
$-21.9M
Ch1m
38.23
Ch1w
27.53
Ch1y
1.28
Ch3m
8.06
Ch3y
-31.41
Ch5y
-54.13
Ch6m
6.04
Change
23.8%
Change From Open
1.41
Close
19.16
Days Gap
22.08
Depreciation Amortization
5,323,000
Dollar Volume
104,641,183.2
Earnings Date
2026-05-07
Earnings Time
amc
EBIT
$104.2M
EBITDA
$109.5M
EPS
$0.76
F Score
6
FCF
$184.4M
FCF EV Yield
11.24x
FCF Per Share
$2.37
Financing CF
-219,188,000
Fiscal Year End
December
Founded
2,008
Goodwill
19,879,000
Graham Number
9.86342
Graham Upside
-58.42
Income Tax
$38.1M
Investing CF
32,191,000
Ipr
82.46
Iprfo
75.7
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-27
Lynch Fair Value
$3.82
Lynch Upside
-83.89
Ma150
21.5
Ma150ch
10.33%
Ma20
18.5
Ma20ch
28.24%
Net CF
19,332,000
Next Earnings Date
2026-08-06
Open
23.39
Optionable
Yes
P FCF Ratio
9.99
P OCF Ratio
8.93
Position In Range
98.44
Post Close
23.72
Postmarket Change Percent
-0.76
Postmarket Price
$23.54
Ppne
59,984,000
Pre Close
19.16
Price Date
2026-05-08
Price EBITDA
$16.82
Ptbv Ratio
4.45
Relative Volume
2.81x
Revenue
1,293,127,000x
SBC By Revenue
9.21x
Share Based Comp
119,076,000
Tax By Revenue
2.95x
Tax Rate
36%
Tr6m
6.04%
Us State
New York
Volume
4,411,517
Z Score
7.68
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does PGNY pay a dividend?

Capital-return profile for this ticker.

Performance

PGNY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+1.3%
S&P 500 1Y: n/a
3Y total return
-31.4%
S&P 500 3Y: n/a
5Y total return
-54.1%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns PGNY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+105.3%
Float: +91.5% of shares outstanding
Insider ownership
+1.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+7.8%
4.2 days to cover
Y/Y dilution
-4.1%
Negative means the company is buying back shares.
Technical

PGNY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
83.9
Above 70: short-term overbought
Price vs 200-day MA
+8.9%
50/200-day relationship not available
Beta (5Y)
0.91
Moves roughly with the market
Sharpe ratio
0.23
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About PGNY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PGNY stock rating?

Progyny, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PGNY analysis?

The full report lives at /stocks/PGNY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PGNY?

The latest report frames PGNY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PGNY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.